Characterization of Antiplatelet Properties of Silver Nanoparticles

Lytic cycle
DOI: 10.1021/nn900277t Publication Date: 2009-05-04T14:33:42Z
ABSTRACT
Thrombotic disorders have emerged as serious threat to society. As anticoagulant and thrombolytic therapies are usually associated with bleeding complications, the focus has now shifted regulating maintaining platelets in an inactive state. In present study we show that nanosilver innate antiplatelet property effectively prevents integrin-mediated platelet responses, both vivo vitro, a concentration-dependent manner. Ultrastructural studies accumulates within granules reduces interplatelet proximity. Our findings further suggest these nanoparticles do not confer any lytic effect on thus hold potential be promoted antiplatelet/antithrombotic agents after careful evaluation of toxic effects.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (47)
CITATIONS (271)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....